Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients.
Hacettepe University Medical School, Department of Internal Medicine, Ankara, Turkey.
N
N
Sayinalp
Y
Y
Erdem
O
O
Ilhami Ozcebe
Y
Y
Büyükaşik
S
S
Cağlar
S V
SV
Dündar
D000328:Adult; D002908:Chronic Disease; D004921:Erythropoietin / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D006435:Renal Dialysis; D013997:Time Factors
D011994:Recombinant Proteins; D004921:Erythropoietin